About V-Wave
V-Wave is a company based in Caesarea (Israel) founded in 2009 was acquired by Johnson & Johnson in August 2024.. V-Wave has raised $128 million across 4 funding rounds from investors including Johnson & Johnson, Edwards Lifesciences and Deerfield. V-Wave offers products and services including Ventura Interatrial Shunt System. V-Wave operates in a competitive market with competitors including Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
- Headquarter Caesarea, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name V-Wave Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$128 M (USD)
in 4 rounds
-
Latest Funding Round
$28 M (USD), Series C
Sep 23, 2020
-
Investors
Johnson & Johnson
& 13 more
-
Employee Count
Employee Count
-
Acquired by
Johnson & Johnson
(Aug 20, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of V-Wave
V-Wave offers a comprehensive portfolio of products and services, including Ventura Interatrial Shunt System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device improves blood flow for heart failure patients through innovative shunt technology.
Unlock access to complete
Funding Insights of V-Wave
V-Wave has successfully raised a total of $128M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $28 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $28.0M
-
First Round
First Round
(03 Jul 2013)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series C - V-Wave | Valuation | Deerfield | |
| Jun, 2017 | Amount | Series C - V-Wave | Valuation | Deerfield | |
| Jan, 2016 | Amount | Series B - V-Wave | Valuation | Pura Vida Investments , Johnson & Johnson Innovation – JJDC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in V-Wave
V-Wave has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, Edwards Lifesciences and Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by V-Wave
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - V-Wave
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
V-Wave Comparisons
Competitors of V-Wave
V-Wave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Implantable technology for hypertension and heart failure is developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized ventricular assist devices are developed for heart failure treatment.
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
|
| domain | founded_year | HQ Location |
Total artificial hearts are developed for cardiac replacement therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on V-Wave
Frequently Asked Questions about V-Wave
When was V-Wave founded?
V-Wave was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Where is V-Wave located?
V-Wave is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
Is V-Wave a funded company?
V-Wave is a funded company, having raised a total of $128M across 4 funding rounds to date. The company's 1st funding round was a Series B of $28M, raised on Jul 03, 2013.
What does V-Wave do?
V-Wave was founded in 2009 in Caesarea, Israel, within the medical devices sector. Percutaneous implantable devices are developed by the company to address chronic heart failure in patients. An inter-atrial shunt is offered as a key product to regulate left atrial pressure and alleviate symptoms. FDA approval has been secured for this device, supporting its clinical use.
Who are the top competitors of V-Wave?
V-Wave's top competitors include Sequana Medical, CVRx and Adona Medical.
What products or services does V-Wave offer?
V-Wave offers Ventura Interatrial Shunt System.
Who are V-Wave's investors?
V-Wave has 14 investors. Key investors include Johnson & Johnson, Edwards Lifesciences, Deerfield, Endeavour Vision, and Quark Venture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.